| 000 -LEADER |
|---|
| fixed length control field |
03460nam a22004695i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
978-0-387-71996-2 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20161121230735.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100301s2007 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780387719962 |
| -- |
978-0-387-71996-2 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1007/978-0-387-71996-2 |
| Source of number or code |
doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RA1-1270 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MBN |
| Source |
bicssc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED078000 |
| Source |
bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
613 |
| Edition number |
23 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
614 |
| Edition number |
23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Schlander, Michael. |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Health Technology Assessments by the National Institute for Health and Clinical Excellence |
| Medium |
[electronic resource] : |
| Remainder of title |
A Qualitative Study / |
| Statement of responsibility, etc. |
by Michael Schlander. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York, NY : |
| Name of producer, publisher, distributor, manufacturer |
Springer New York, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2007. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XXX, 245 p. |
| Other physical details |
online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Innovation and Valuation in Health Care |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
A Note on Objectives and Methods -- NICE Appraisal Process -- NICE Appraisal of ADHD Treatments -- NICE Appraisal of ADHD Treatment Options: A Critique -- Discussion and Implications -- Which Way Forward?. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
First in a new series on economic issues in the context of health care policy, Health Technology Assessments by the National Institute for Health and Clinical Excellence examines Britain’s highly acclaimed approach to cost-effectiveness analysis (CEA), and its international potential. The National Institute for Health and Clinical Excellence (NICE) has been regarded as a role model for the implementation of CEA, and is being closely watched by health care policy makers throughout Europe, and in the United States. This volume dissects the robustness of the agency’s technology appraisal processes as NICE evaluates innovative methods for diagnosis and intervention. Given the unique features of attention-deficit/hyperactivity disorder (ADHD)—starting with it being diagnosed mainly in children and adolescents, its high comorbidity with other psychiatric conditions, and its considerable economic impact—the disorder is a perfect focal point for discussion. Review of clinical issues in ADHD, including diagnostic criteria and the use of psychostimulants. Step-by-step explanation of the NICE appraisal process: valuation of treatment strategies for ADHD. Successes and limitations of NICE: an in-depth critique. Future directions and implications for health care prioritization in other countries. Balanced clinical and economic perspectives throughout the book. This is salient reading for public health professionals in health service administration, research, policy, and economics. Whether one’s interest is the robustness of the NICE method, or its application across clinical conditions or delivery systems, this book is a singular look into the real world of health care decision-making. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Public health. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Health administration. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Health Administration. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Printed edition: |
| International Standard Book Number |
9780387719955 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Innovation and Valuation in Health Care |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-0-387-71996-2 |
| 912 ## - |
|---|
| -- |
ZDB-2-SME |
